Small Molecule CROs in Europe
28 published
28 published CROs match Small Molecule in Europe.
Locations in this set include United States, United Kingdom, France, Germany, Australia, and China.
Capabilities that show up most often in this set: Regulatory Affairs, Bioanalysis, Biomarker Assays, Phase I Clinical Trials, and Phase II Clinical Trials.
Matching companies
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Reaction BiologyGlobal preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
Simbec-OrionFull-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.
SolviasGlobal cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.
Sygnature DiscoveryIntegrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
Velocity Clinical ResearchIntegrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /modalities/small-molecule/europe.md